Schizophrenia
|
0.370 |
Biomarker
|
disease |
BEFREE |
In one of the largest sequencing studies of schizophrenia to date, we provide novel evidence that multiple voltage-gated sodium channels are involved in schizophrenia pathogenesis and confirm the involvement of ARC and NMDAR postsynaptic complexes.
|
30420267 |
2019 |
Schizophrenia
|
0.370 |
Biomarker
|
disease |
BEFREE |
Together, results indicate an important role of dysbindin-1 in neuronal activity induced SREBP1 and ARC, which could be related to cognitive deficits in schizophrenia.
|
26873854 |
2017 |
Schizophrenia
|
0.370 |
GeneticVariation
|
disease |
BEFREE |
Building on this, we finally compare and evaluate several lines of evidence demonstrating that Arc genetics can alter both glutamatergic and dopaminergic systems in a very selective way, again consistent with molecular alterations characteristic of schizophrenia.
|
28979198 |
2017 |
Schizophrenia
|
0.370 |
Biomarker
|
disease |
BEFREE |
No enrichment was observed for activity-regulated cytoskeleton-associated protein (P=0.23) or N-methyl-D-aspartate receptor (P=0.74) post-synaptic signalling gene sets previously implicated in schizophrenia.
|
26573769 |
2016 |
Schizophrenia
|
0.370 |
Biomarker
|
disease |
BEFREE |
SNP-based analysis showed no association of ARC with schizophrenia.
|
27464451 |
2016 |
Schizophrenia
|
0.370 |
Biomarker
|
disease |
BEFREE |
Accordingly, variations in the immediate early gene EGR3, and its target ARC, should influence schizophrenia susceptibility.
|
26474411 |
2015 |
Schizophrenia
|
0.370 |
Biomarker
|
disease |
PSYGENET |
Our data indicate that defects in NMDAR postsynaptic signalling and, possibly, ARC complexes, which are known to be important in synaptic plasticity and cognition, play a significant role in the pathogenesis of schizophrenia.
|
22083728 |
2012 |
Schizophrenia
|
0.370 |
Biomarker
|
disease |
BEFREE |
Our data indicate that defects in NMDAR postsynaptic signalling and, possibly, ARC complexes, which are known to be important in synaptic plasticity and cognition, play a significant role in the pathogenesis of schizophrenia.
|
22083728 |
2012 |
Alzheimer's Disease
|
0.330 |
Biomarker
|
disease |
BEFREE |
In this study, a two-stage case-control study of 1471 Han Chinese was conducted to investigate the genetic association between the Arc gene and AD.
|
28108859 |
2018 |
Alzheimer's Disease
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
In this study, we investigated genetic variation in human ARC and the risk of developing AD.
|
22622366 |
2012 |
Alzheimer's Disease
|
0.330 |
Biomarker
|
disease |
CTD_human |
Finally, we showed that Arc levels are decreased in the cortex of AD brains.
|
18503570 |
2009 |
Alzheimer's Disease
|
0.330 |
Biomarker
|
disease |
BEFREE |
In addition, levels of mRNAs encoding proteins not previously implicated in AD were reduced in CA1 tangle-bearing neurons, suggesting that these proteins (eg, activity-regulated cytoskeleton-associated protein, focal adhesion kinase, glutaredoxin, utrophin) may be novel mediators of NFT formation or degeneration in affected neurons.
|
10894219 |
2000 |
Alzheimer Disease, Late Onset
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
In the brain insulin system, IGF2R, INSR, INSRR, and plasticity regulator ARC, were associated with LOAD.
|
30386171 |
2018 |
Alcoholic Intoxication, Chronic
|
0.310 |
Biomarker
|
disease |
PSYGENET |
The role of amygdaloid brain-derived neurotrophic factor, activity-regulated cytoskeleton-associated protein and dendritic spines in anxiety and alcoholism.
|
21182574 |
2011 |
Alcoholic Intoxication, Chronic
|
0.310 |
Biomarker
|
disease |
PSYGENET |
Study of the downstream effectors of CREB have identified several important CREB-related genes, such as neuropeptide Y, brain-derived neurotrophic factor, activity-regulated cytoskeleton-associated protein, and corticotrophin-releasing factor, that may play a crucial role in the behavioral effects of ethanol and molecular changes in the specific neurocircuitry that underlie both alcohol addiction and a genetic predisposition to alcoholism.
|
19756388 |
2010 |
Alcoholic Intoxication, Chronic
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Study of the downstream effectors of CREB have identified several important CREB-related genes, such as neuropeptide Y, brain-derived neurotrophic factor, activity-regulated cytoskeleton-associated protein, and corticotrophin-releasing factor, that may play a crucial role in the behavioral effects of ethanol and molecular changes in the specific neurocircuitry that underlie both alcohol addiction and a genetic predisposition to alcoholism.
|
19756388 |
2010 |
Alzheimer Disease, Late Onset
|
0.310 |
Biomarker
|
disease |
CTD_human |
Activity-regulated cytoskeleton-associated protein in rodent brain is down-regulated by high fat diet in vivo and by 27-hydroxycholesterol in vitro.
|
18503570 |
2009 |
Alcoholic Intoxication, Chronic
|
0.310 |
Biomarker
|
disease |
PSYGENET |
However, the role of Arc in alcoholism is unknown.
|
18322102 |
2008 |
Movement Disorders
|
0.300 |
Biomarker
|
group |
CTD_human |
Methamphetamine-induced stereotypy correlates negatively with patch-enhanced prodynorphin and arc mRNA expression in the rat caudate putamen: the role of mu opioid receptor activation.
|
20298714 |
2010 |
Etat Marbre
|
0.300 |
Biomarker
|
disease |
CTD_human |
Methamphetamine-induced stereotypy correlates negatively with patch-enhanced prodynorphin and arc mRNA expression in the rat caudate putamen: the role of mu opioid receptor activation.
|
20298714 |
2010 |
Presenile dementia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Activity-regulated cytoskeleton-associated protein in rodent brain is down-regulated by high fat diet in vivo and by 27-hydroxycholesterol in vitro.
|
18503570 |
2009 |
Familial Alzheimer Disease (FAD)
|
0.300 |
Biomarker
|
disease |
CTD_human |
Activity-regulated cytoskeleton-associated protein in rodent brain is down-regulated by high fat diet in vivo and by 27-hydroxycholesterol in vitro.
|
18503570 |
2009 |
Acute Confusional Senile Dementia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Activity-regulated cytoskeleton-associated protein in rodent brain is down-regulated by high fat diet in vivo and by 27-hydroxycholesterol in vitro.
|
18503570 |
2009 |
Alzheimer's Disease, Focal Onset
|
0.300 |
Biomarker
|
disease |
CTD_human |
Activity-regulated cytoskeleton-associated protein in rodent brain is down-regulated by high fat diet in vivo and by 27-hydroxycholesterol in vitro.
|
18503570 |
2009 |
Alzheimer Disease, Early Onset
|
0.300 |
Biomarker
|
disease |
CTD_human |
Activity-regulated cytoskeleton-associated protein in rodent brain is down-regulated by high fat diet in vivo and by 27-hydroxycholesterol in vitro.
|
18503570 |
2009 |